DDAH1 regulates apoptosis and angiogenesis in human fetal pulmonary microvascular endothelial cells
Open Access
- 17 June 2019
- journal article
- research article
- Published by Wiley in Physiological Reports
- Vol. 7 (12) , e14150
Abstract
Nitric Oxide (NO) is an endogenous pulmonary vasodilator produced by endothelial NO synthase (eNOS). Asymmetric dimethyl L‐arginine (ADMA) is an endogenous inhibitor of eNOS activity. In endothelial cells, ADMA is hydrolyzed to L‐citrulline primarily by dimethylarginine dimethyl‐aminohydrolase‐1 (DDAH1). We tested the hypothesis that DDAH1 expression is essential for maintaining NO production in human fetal pulmonary microvascular endothelial cells (hfPMVEC), such that knockdown of DDAH1 expression will lead to decreased NO production resulting in less caspase‐3 activation and less tube formation. We found that hfPMVEC transfected with DDAH1 siRNA had lower NO production than control, with no difference in eNOS protein levels between groups. hfPMVEC transfected with DDAH1 siRNA had lower protein levels of cleaved caspase‐3 and ‐8 than control. Both DDAH1 siRNA‐ and ADMA‐treated hfPMVEC had greater numbers of viable cells than controls. Angiogenesis was assessed using tube formation assays in matrigel, and tube formation was lower after either DDAH1 siRNA transfection or ADMA treatment than controls. Addition of an NO donor restored cleaved caspase‐3 and ‐8 protein levels after DDAH1 siRNA transfection in hfPMVEC to essentially the levels seen in scramble control. Addition of a putative caspase‐3 inhibitor to DDAH1 siRNA transfected and NO‐donor treated cells led to greater numbers of viable cells and far less angiogenesis than in any other group studied. We conclude that in hfPMVEC, DDAH1 is central to the regulation of NO‐mediated caspase‐3 activation and the resultant apoptosis and angiogenesis. Our findings suggest that DDAH1 may be a potential therapeutic target in pulmonary hypertensive disorders.Keywords
Funding Information
- National Institutes of Health (K08HL129080)
This publication has 54 references indexed in Scilit:
- Overexpression of cationic amino acid transporter‐1 increases nitric oxide production in hypoxic human pulmonary microvascular endothelial cellsClinical and Experimental Pharmacology and Physiology, 2011
- Sepiapterin improves angiogenesis of pulmonary artery endothelial cells with in utero pulmonary hypertension by recoupling endothelial nitric oxide synthaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Nitric oxide suppression of cellular proliferation depends on cationic amino acid transporter activity in cytokine-stimulated pulmonary endothelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Nitrotyrosine Impairs Angiogenesis and Uncouples eNOS Activity of Pulmonary Artery Endothelial Cells Isolated From Developing Sheep LungsPediatric Research, 2011
- Hypoxia-induced proliferation of human pulmonary microvascular endothelial cells depends on epidermal growth factor receptor tyrosine kinase activationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Apoptotic Cells Activate the “Phoenix Rising” Pathway to Promote Wound Healing and Tissue RegenerationScience Signaling, 2010
- Vascular Endothelial-Specific Dimethylarginine Dimethylaminohydrolase-1–Deficient Mice Reveal That Vascular Endothelium Plays an Important Role in Removing Asymmetric DimethylarginineCirculation, 2009
- Role of Dimethylarginine Dimethylaminohydrolases in the Regulation of Endothelial Nitric Oxide ProductionJournal of Biological Chemistry, 2009
- Role of the PRMT–DDAH–ADMA axis in the regulation of endothelial nitric oxide productionPharmacological Research, 2009
- Increased superoxide production contributes to the impaired angiogenesis of fetal pulmonary arteries with in utero pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009